OrbiMed

OrbiMed

OrbiMed

From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will he
Founded
1989
Follow us
28 Oct 2020

CAR-T Biotech Firm Gracell Completes $100 Million Round – China Money Network

ChinaMoneyNetwork
+1
31 Aug 2020

Erasca Completes $36M Extension of Series B Financing

FinSMEs
+1
10 Jul 2020
$102,800,000
Venture capital (Series C)
OrbiMed, GTJA Investment Group, Sage Partners, +4

Chinese Biotech Startup Harbour BioMed Secures $102.8M In Series C Round – China Money Network

ChinaMoneyNetwork
+2
08 Jul 2020
$137,000,000
Venture capital (Series B)

VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs

Xconomy
+1
27 May 2020
$105,000,000
Venture capital (Series B)
OrbiMed, DCVC Bio

AbCellera Raises $105 Million To Boost Drug Discovery Against Coronavirus And Other Diseases

Forbes Tech
+2
21 Dec 2019
$74,500,000
Venture capital (Series B)

Precision Oncology Company Kinnate Biopharma Raises $74.5 Million

Pulse 2.0
+1